Ocuphire Pharma Results Presentation Deck
11
ZETA-1: Baseline DRSS Scores Study and Fellow Eye
Well-Balanced Across Arms
DRSS Score - Study Eye
DRSS Category (Screening) Study Eye [n (%)]
47 (Moderately severe to severe NPDR)
53 (Moderately severe to severe NPDR)
61 (Mild proliferative diabetic retinopathy)
DRSS Score - Fellow Eye
DRSS Category (Screening) Fellow Eye [n (%)]
43 or Lower (Mild to moderate NDPR or better)
47 (Moderately severe to severe NPDR)
53 (Moderately severe to severe NPDR)
61 (Mild proliferative diabetic retinopathy)
65 or Higher (Moderate to severe prolif. DR)
Source: ZETA-1 Clinical Trial
APX3330
n=51
22 (43%)
25 (49%)
4 (8%)
APX3330
n=45
14 (31%)
13 (29%)
12 (27%)
1 (2%)
5 (11%)
Placebo
n=52
18 (35%)
28 (54%)
6 (12%)
Placebo
n=49
12 (24%)
19 (39%)
9 (19%)
4 (8%)
5 (10%)
Total
n=103
40 (39%)
53 (52%)
10 (10%)
Total
n=94
26 (28%)
32 (34%)
21 (22%)
5 (5%)
10 (11%)
OcuphireView entire presentation